StonvexLoading…
StonvexStonvexStonvexCore line items from AIRI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $11.61M | $47.92M | $35.11M | $24.80M |
Operating Income | $-565.00K | $-338.00K | $-422.00K | $-738.00K |
Net Income | $-1.02M | $-1.30M | $-1.45M | $-422.00K |
EPS (Diluted) | $-0.21 | $-0.31 | $-0.36 | $-0.38 |
Total Assets | $59.22M | $58.33M | $57.95M | $50.38M |
Total Liabilities | $40.07M | $39.13M | $39.11M | $35.11M |
Cash & Equivalents | $4.22M | $4.61M | $4.06M | $507.00K |
Free Cash Flow OCF − CapEx | $-1.72M | $-4.67M | $-3.77M | $-243.00K |
Shares Outstanding | 4.78M | 4.78M | 4.77M | 3.86M |